R-2487 in Patients With Rheumatoid Arthritis

Summary

The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.

Timeline

Start

2023-10-19

Primary completion

2026-11-30

Completion

2026-12-31

Drugs

Indications